FDA Orders Philips To Improve Communications To Patients
(March 10, 2022) — Many users of Philips’ sleep apnea machines have expressed frustration about the lack of communication from Philips after its recall. In an effort to improve communications the Food and Drug Administration [“FDA”] issued a notification order to Philips Respironics requiring the company to notify patients and others of the company’s June 14, 2021, recall of...
Continue Reading